Sep 03, 2020 11:39am EDT Emerald Bioscience to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Aug 13, 2020 8:30am EDT Emerald Bioscience Appoints Biotech Veteran Dr. Margaret Dalesandro to Board of Directors
Aug 04, 2020 6:32pm EDT Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
Jul 31, 2020 9:20am EDT Emerald Bioscience Announces Pricing of $7.0 Million Upsized Registered Offering
Jun 09, 2020 9:37am EDT Emerald Bioscience Announces Presentation of Cannabidiol-Valine-Hemisuccinate Ocular Data at Virtual ARVO® Meeting
Jun 02, 2020 8:30am EDT Emerald Bioscience Announces Awarding of Patent for Cannabidiol-Valine-Hemisuccinate in Japan
Mar 09, 2020 8:30am EDT Emerald Bioscience Announces Notice of Allowance from United States Patent Office for Proprietary Analog of Cannabidiol
Jan 30, 2020 8:30am EST Emerald Bioscience to Present at the 9th Annual Glaucoma 360 New Horizons Forum and BIO CEO & Investor Forum
